About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Still Awaits SIAC Arbitration Update

June 8, 2018

Click here to read more

Post navigation

Retirement of Non-Executive Director

Research Report from NDF Research

Related Posts

Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial

December 8, 2014

Equity Capital Raising Placement of New Shares

September 1, 2014

Dosing commences for Phase I human clinical trial

October 4, 2021October 4, 2021

Recent Posts

First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.